4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-055119
Chief Financial Officer sold 1,099 shares at $21.54 ($23,672)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2022-10-28 | Sale | −1,099 | $21.54 | $23,672 | 50,676 | D |
| Open-market sales · 1,099 sh · avg $21.54 · $23,672 | |||||||
Loading xslF345X03/doc4.xml…